Dr. Ammar Sukari
Claim this profileWayne State University/Karmanos Cancer Institute
Expert in Parotid Gland Cancer
Expert in Squamous Cell Carcinoma
29 reported clinical trials
45 drugs studied
Area of expertise
1Parotid Gland Cancer
Global LeaderStage IV
Stage III
PD-L1 positive
2Squamous Cell Carcinoma
Global LeaderStage IV
PD-L1 positive
Stage III
Affiliated Hospitals
Clinical Trials Ammar Sukari is currently running
EP0031
for Cancer
The aim of this study is to assess the safety, side effects and effectiveness of EP0031 in patients with advanced RET-altered malignancies
Recruiting1 award Phase 1 & 2
Pembrolizumab + Radiation vs Chemotherapy + Radiation
for Head and Neck Cancer
This phase II trial studies the effect of pembrolizumab alone compared to the usual approach (chemotherapy \[cisplatin and carboplatin\] plus radiation therapy) after surgery in treating patients with head and neck squamous cell carcinoma that has come back (recurrent) or patients with a second head and neck cancer that is not from metastasis (primary). Radiation therapy uses high energy radiation or protons to kill tumor cells and shrink tumors. Cisplatin is in a class of medications known as platinum-containing compounds. It works by killing, stopping or slowing the growth of cancer cells. Carboplatin is also in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of cancer cells. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer and may interfere with the ability of tumor cells to grow and spread. Giving pembrolizumab alone after surgery may work better than the usual approach in shrinking recurrent or primary head and neck squamous cell carcinoma.
Recruiting1 award Phase 231 criteria
More about Ammar Sukari
Clinical Trial Related2 years of experience running clinical trials · Led 29 trials as a Principal Investigator · 12 Active Clinical TrialsTreatments Ammar Sukari has experience with
- Cisplatin
- Pembrolizumab
- Nivolumab
- Intensity-Modulated Radiation Therapy
- Carboplatin
- Image Guided Radiation Therapy
Breakdown of trials Ammar Sukari has run
Parotid Gland Cancer
Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma
Oropharyngeal Carcinoma
Non-Small Cell Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
What does Ammar Sukari specialize in?
Is Ammar Sukari currently recruiting for clinical trials?
Are there any treatments that Ammar Sukari has studied deeply?
What is the best way to schedule an appointment with Ammar Sukari?
What is the office address of Ammar Sukari?
Is there any support for travel costs?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.